Evidence map›Paper›PMID 38740641›Full record

ArticleActa neurochirurgica2024

Descriptive epidemiology of 30,223 histopathologically confirmed meningiomas in France: 2006-2015.

Charles Champeaux Depond, Sonia Zouaoui, Amélie Darlix, Valérie Rigau, Hélène Mathieu-Daudé, Fabienne Bauchet, Mohamed Khettab, Brigitte Trétarre, Dominique Figarella-Branger, Luc Taillandier and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Acta neurochirurgica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. WHO grade 3 pediatric meningioma: a systematic review of clinical features and patient-level analysis of prognostic factors.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Pooled it
  2. Article
  3. Article
  4. Meningiomas in Rubinstein-Taybi syndrome: A case report and comprehensive review.Journal of neuropathology and experimental neurology · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Charles Champeaux DepondDepartment of Neurosurgery, Hôpital Privé Clairval - Ramsay Santé, 317 Bd de Redon, 13009, Marseille, France. Charles.ChampeauxDepond@gmail.com.ORCID 0000-0002-0356-0893
Sonia ZouaouiDepartment of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier cedex 5, France.ORCID 0000-0003-0467-3280
Amélie DarlixInstitut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.ORCID 0000-0003-1384-1709
Valérie RigauInstitut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.ORCID 0000-0002-8017-5489
Hélène Mathieu-DaudéDepartment of Epidemiology, French Brain Tumour Database, GNOLR, Registre Des Tumeurs de L'Hérault, ICM, 34298, Montpellier cedex 5, France.
Fabienne BauchetDepartment of Epidemiology, French Brain Tumour Database, GNOLR, Registre Des Tumeurs de L'Hérault, ICM, 34298, Montpellier cedex 5, France.
Mohamed KhettabInstitut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.ORCID 0000-0002-3345-4901
Brigitte TrétarreRegistre Des Tumeurs de L'Hérault, ICM, 34298, Montpellier cedex 5, France.ORCID 0000-0001-8509-949X
Dominique Figarella-BrangerInstitut de Neurophysiopathologie, Service d'Anatomie Pathologique Et de Neuropathologie, Aix-Marseille University, APHM, CNRS, INP, CHU Timone, 13005, Marseille, France.ORCID 0000-0002-3604-887X
Luc TaillandierDepartment of Neurology, University Hospital of Nancy, Nancy, France.ORCID 0000-0002-9422-793X
Julien BoettoDepartment of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier cedex 5, France.ORCID 0000-0003-2572-8594
Johan PalludService de Neurochirurgie, GHU Paris Psychiatrie Et Neurosciences, Site Sainte Anne, 75014, Paris, France.ORCID 0000-0002-1652-9844
Ilyess ZemmouraNeurosurgery Department, CHRU de Tours, Tours, France.ORCID 0000-0002-6241-6955
Pierre-Hugues RocheNeurosurgery Department, CHRU de Tours, Tours, France.ORCID 0000-0002-2397-4700
Luc BauchetDepartment of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier cedex 5, France.ORCID 0000-0003-1077-2496
French Brain Tumour DataBase (FBTDB) Participants, Investigators with the participation of the Société française de neurochirurgie (SFNC)
Club de neuro-oncologie de la société française de neurochirurgie, Société française de neuropathologie (SFNP)
Association des neuro-oncologues d’expression française (ANOCEF)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesMeningioma is one of the most common neoplasm of the central nervous system. To describe the epidemiology of meningioma operated in France and, to assess grading and histopathological variability among the different neurosurgical centres.

methodsWe processed the French Brain Tumour Database (FBTDB) to conduct a nationwide population-based study of all histopathologically confirmed meningiomas between 2006 and 2015.

results30,223 meningiomas cases were operated on 28,424 patients, in 61 centres. The average number of meningioma operated per year in France was 3,022 (SD ± 122). Meningioma was 3 times more common in women (74.1% vs. 25.9%). The incidence of meningioma increased with age and, mean age at surgery was 58.5 ± 13.9 years. Grade 1, 2, and 3 meningiomas accounted for 83.9%, 13.91% and, 2.19% respectively. There was a significant variability of meningioma grading by institutions, especially for grade 2 which spanned from 5.1% up to 22.4% (p < 0.001). Moreover, the proportion of grade 2 significantly grew over the study period (p < 0.001). There was also a significant variation in grade 1 subtypes diagnosis among the institutions (p < 0.001). 89.05% of the patients had solely one meningioma surgery, 8.52% two and, 2.43% three or more. The number of surgeries was associated to the grade of malignancy (p < 0.001).

conclusionThe incidence of meningioma surgery increased with age and, peaked at 58.5 years. They were predominantly benign with meningothelial subtype being the most common. However, there was a significant variation of grade 1 subtypes diagnosis among the centres involved. The proportion of grade 2 meningioma significantly grew over the study time, on contrary to malignant meningioma proportion, which remained rare and, stable over time around 2%. Likewise, there was a significant variability of grade 2 meningioma rate among the institutions.

Indexed as

Meningeal NeoplasmsMeningiomaAdolescentAdultAgedAged, 80 and overDatabases, FactualFemaleFranceHumansIncidenceMaleMiddle AgedNeoplasm GradingYoung AdultDatabaseEpidemiologyGradeMeningiomaNationwideSubtypes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.